血管微生理系统 (MPS):生物相关和强效模型.
Lucas Breuil1, Atsuya Kitada1, Sachin Yadav1
1Department of Micro Engineering, Kyoto University, Kyoto Daigaku-katsura, Nishikyo-ku, Kyoto 615-8540, Japan. yokokawa.ryuji.8c@kyoto-u.ac.jp.
Lab on a chip
|July 4, 2025
概括
血管微生理系统 (MPS) 为研究血管生物学提供先进的3D模型. 这些器官芯片系统克服了血管研究和药物开发传统模型的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 血管生物学 血管生物学
- 微流体学 微流体学
背景情况:
- 传统的体外模型缺乏本地血管系统的复杂性.
- 在体内模型提出伦理和生理相关性挑战.
- 需要先进的模型来研究血管生物学和病理学.
研究的目的:
- 审查血管微生理系统 (MPS) 的相关性和能力.
- 突出MPS如何克服传统研究模式的局限性.
- 讨论MPS在疾病建模和药物开发中的应用.
主要方法:
- 利用微流体通道和3D结构来创建血管MPS.
- 包括多种不同的细胞和非细胞组成部分.
- 模仿血管的生理微观环境.
主要成果:
- 血管MPS复制3D架构和多组件交互.
- 这些系统可以研究血管对生理线索的反应.
- MPS促进了与血管健康和疾病相关的复杂生物过程.
结论:
- 血管MPS代表了一种强大的体外工具,用于推进血管生物学.
- 器官芯片技术提供了生理学上相关的模型.
- 血管MPS对于疾病建模和加速药物发现至关重要.
相关概念视频
Mechanistic Models: Overview of Compartment Models
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...


